Reframing renal denervation: from blood pressure reduction to autonomic disease modification—a state-of-the-art review
Background Renal denervation (RDN) has re-emerged as an evidence-based treatment for uncontrolled and resistant hypertension following consistent findings from contemporary sham-controlled randomized trials. Because renal sympathetic signaling plays a central role in cardiovascular (CV), renal, and metabolic homeostasi...